(AOSL) Alpha Omega Semiconductor - Overview
Stock: Power, Discrete, ICs, Protection, SiC, Modules
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 57.0% |
| Relative Tail Risk | -13.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.56 |
| Alpha | -78.75 |
| Character TTM | |
|---|---|
| Beta | 2.729 |
| Beta Downside | 2.899 |
| Drawdowns 3y | |
|---|---|
| Max DD | 66.94% |
| CAGR/Max DD | -0.14 |
Description: AOSL Alpha Omega Semiconductor January 26, 2026
Alpha and Omega Semiconductor Ltd. (NASDAQ:AOSL) designs and manufactures a broad portfolio of power semiconductor components-including MOSFETs, IGBTs, power ICs, and silicon-carbide devices-targeting computing, consumer electronics, communications, and industrial markets worldwide, with operations spanning Hong Kong, China, South Korea, the United States, and other regions.
According to the company’s most recent FY 2024 filing, revenue reached approximately **$152 million**, up **22 % year-over-year**, while gross margin improved to **38 %** and cash on hand stood at **$81 million**. R&D expenditure averaged **12 % of revenue**, reflecting a continued focus on expanding its silicon-carbide and high-voltage product lines.
The power-semiconductor sector is being driven by three macro trends: (1) the global market for power devices is projected to grow at a **CAGR of ~8 % through 2030**, fueled by electrification; (2) AI-intensive data centers and EV adoption are accelerating demand for high-efficiency MOSFETs and SiC modules, with EV sales rising **≈15 % YoY** in 2024; and (3) U.S. CHIPS Act incentives are creating financing opportunities for domestic fab capacity, potentially benefitting AOSL’s Sunnyvale-based operations.
For a deeper, data-rich assessment of AOSL’s valuation metrics and scenario analysis, you may find the **ValueRay** platform useful as a next step in your research.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: -96.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -0.36 > 1.0 |
| NWC/Revenue: 53.10% < 20% (prev 38.12%; Δ 14.98% < -1%) |
| CFO/TA 0.03 > 3% & CFO 28.8m > Net Income -96.6m |
| Net Debt (-190.7m) to EBITDA (36.8m): -5.18 < 3 |
| Current Ratio: 3.29 > 1.5 & < 3 |
| Outstanding Shares: last quarter (30.0m) vs 12m ago 3.56% < -2% |
| Gross Margin: 22.87% > 18% (prev 0.25%; Δ 2261 % > 0.5%) |
| Asset Turnover: 64.07% > 50% (prev 57.89%; Δ 6.18% > 0%) |
| Interest Coverage Ratio: -11.59 > 6 (EBITDA TTM 36.8m / Interest Expense TTM 2.19m) |
Altman Z'' 6.57
| A: 0.36 (Total Current Assets 531.3m - Total Current Liabilities 161.3m) / Total Assets 1.04b |
| B: 0.51 (Retained Earnings 531.8m / Total Assets 1.04b) |
| C: -0.02 (EBIT TTM -25.4m / Avg Total Assets 1.09b) |
| D: 2.59 (Book Value of Equity 526.7m / Total Liabilities 203.4m) |
| Altman-Z'' Score: 6.57 = AAA |
Beneish M -1.80
| DSRI: 2.84 (Receivables 93.5m/31.1m, Revenue 696.8m/658.5m) |
| GMI: 1.10 (GM 22.87% / 25.13%) |
| AQI: 0.50 (AQ_t 0.17 / AQ_t-1 0.33) |
| SGI: 1.06 (Revenue 696.8m / 658.5m) |
| TATA: -0.12 (NI -96.6m - CFO 28.8m) / TA 1.04b) |
| Beneish M-Score: -1.80 (Cap -4..+1) = B |
What is the price of AOSL shares?
Over the past week, the price has changed by +0.04%, over one month by +5.43%, over three months by -16.94% and over the past year by -48.05%.
Is AOSL a buy, sell or hold?
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the AOSL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 24.3 | 8.1% |
| Analysts Target Price | 24.3 | 8.1% |
| ValueRay Target Price | 21.3 | -5.6% |
AOSL Fundamental Data Overview February 03, 2026
P/S = 0.9535
P/B = 0.7965
P/EG = -8.49
Revenue TTM = 696.8m USD
EBIT TTM = -25.4m USD
EBITDA TTM = 36.8m USD
Long Term Debt = 2.88m USD (from longTermDebt, last quarter)
Short Term Debt = 9.73m USD (from shortTermDebt, last quarter)
Debt = 32.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -190.7m USD (from netDebt column, last quarter)
Enterprise Value = 473.6m USD (664.4m + Debt 32.8m - CCE 223.5m)
Interest Coverage Ratio = -11.59 (Ebit TTM -25.4m / Interest Expense TTM 2.19m)
EV/FCF = -40.94x (Enterprise Value 473.6m / FCF TTM -11.6m)
FCF Yield = -2.44% (FCF TTM -11.6m / Enterprise Value 473.6m)
FCF Margin = -1.66% (FCF TTM -11.6m / Revenue TTM 696.8m)
Net Margin = -13.86% (Net Income TTM -96.6m / Revenue TTM 696.8m)
Gross Margin = 22.87% ((Revenue TTM 696.8m - Cost of Revenue TTM 537.5m) / Revenue TTM)
Gross Margin QoQ = 23.48% (prev 23.40%)
Tobins Q-Ratio = 0.46 (Enterprise Value 473.6m / Total Assets 1.04b)
Interest Expense / Debt = 1.10% (Interest Expense 360.0k / Debt 32.8m)
Taxrate = 21.0% (US default 21%)
NOPAT = -20.0m (EBIT -25.4m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 3.29 (Total Current Assets 531.3m / Total Current Liabilities 161.3m)
Debt / Equity = 0.04 (Debt 32.8m / totalStockholderEquity, last quarter 834.1m)
Debt / EBITDA = -5.18 (Net Debt -190.7m / EBITDA 36.8m)
Debt / FCF = 16.49 (negative FCF - burning cash) (Net Debt -190.7m / FCF TTM -11.6m)
Total Stockholder Equity = 861.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -8.88% (Net Income -96.6m / Total Assets 1.04b)
RoE = -11.22% (Net Income TTM -96.6m / Total Stockholder Equity 861.3m)
RoCE = -2.93% (EBIT -25.4m / Capital Employed (Equity 861.3m + L.T.Debt 2.88m))
RoIC = -2.26% (negative operating profit) (NOPAT -20.0m / Invested Capital 885.0m)
WACC = 15.26% (E(664.4m)/V(697.1m) * Re(15.97%) + D(32.8m)/V(697.1m) * Rd(1.10%) * (1-Tc(0.21)))
Discount Rate = 15.97% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.68%
Fair Price DCF = unknown (Cash Flow -11.6m)
EPS Correlation: -78.38 | EPS CAGR: -44.72% | SUE: 0.99 | # QB: 1
Revenue Correlation: -33.65 | Revenue CAGR: -1.52% | SUE: -0.23 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.13 | Chg30d=+0.000 | Revisions Net=+0 | Analysts=3
EPS current Year (2026-06-30): EPS=-0.15 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=-168.2% | Growth Revenue=-5.2%
EPS next Year (2027-06-30): EPS=0.23 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+251.1% | Growth Revenue=+6.6%